visions pv .035 - transducer assembly, ultrasound, diagnostic, intracorporeal, intravascular, single-use
life healthcare pty ltd -
quatricide pv liq liquid
pharmacal research labs inc - didecyl dimethyl ammonium chloride; benzalkonium chloride - liquid - 2.31%; 1.54% - didecyl dimethyl ammonium chloride 2.31%; benzalkonium chloride 1.54% - disinfectants (for agents used on object)
quatricide pv-15 second generation liquid
pharmacal research labs inc - didecyl dimethyl ammonium chloride; benzalkonium chloride - liquid - 10.14%; 6.76% - didecyl dimethyl ammonium chloride 10.14%; benzalkonium chloride 6.76% - disinfectants (for agents used on object)
quatricide pv second generation liquid
pharmacal research labs inc - didecyl dimethyl ammonium chloride; benzalkonium chloride - liquid - 2.53%; 1.69% - didecyl dimethyl ammonium chloride 2.53%; benzalkonium chloride 1.69% - disinfectants (for agents used on object)
ster-san pv solution
nitmoi labs inc - benzalkonium chloride; alkyl dimethyl ethylbenzyl ammonium chloride - solution - 0.8%; 0.8% - benzalkonium chloride 0.8%; alkyl dimethyl ethylbenzyl ammonium chloride 0.8% - disinfectants (for agents used on object)
ster-san pv-rtu spray
nitmoi labs inc - benzalkonium chloride; alkyl dimethyl ethylbenzyl ammonium chloride - spray - 0.105%; 0.105% - benzalkonium chloride 0.105%; alkyl dimethyl ethylbenzyl ammonium chloride 0.105% - disinfectants (for agents used on object)
jakavi 10 mg
novartis israel ltd - ruxolitinib as phosphate - tablets - ruxolitinib as phosphate 10 mg - ruxolitinib - * myelofibrosis (mf) jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. * polycythaemia vera (pv) jakavi is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.*graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies
titan copper hydroxide 400 wg fungicide
industrias quimicas del valles, s.a. - copper (cu) present as cupric hydroxide - water dispersible granule - copper (cu) present as cupric hydroxide mineral-copper active 400.0 g/kg - fungicide
handshield pv 10% solution
microgen hygiene private limited, india - povidone iodine - solution - 10
defensor 3 solution for injection
zoetis inc., united states - rabies virus strain pv-paris-bhk/purif. pass 3, svr-289 - solution for injection - 10.7 tcid50/ml